Navigation Links
Pregis Announces Fourth Quarter and Full Year 2008 Financial Results
Date:3/26/2009

(13,121) 12,269 Accrued taxes (6,373) (5,695) Accrued interest 68 467 Other current liabilities (7,014) (382) Pension and related assets and liabilities, net (3,149) (2,726) Other, net 3,421 1,185 ----- ----- Cash provided by operating activities 39,654 51,175 ------ ------ Investing activities Capital expenditures (30,882) (34,626) Proceeds from sale of assets 1,063 775 Other business acquisitions, net of cash acquired (958) (28,785) Insurance proceeds 3,205 884 Other, net (969) (226) ---- ---- Cash used in investing activities (28,541) (61,978) ------- ------- Financing activities Proceeds from issuance of long-term debt (115) 218 Repayment of long-term debt (1,893) (1,828) Deferred financing costs - (1,237) --- ------ Cash used in financing activities (2,008) (2,847) Effect of exchange rate changes on cash and cash equivalents (2,915) 2,972 ------ ----- Increase (decrease) in cash and cash equivalents 6,190 (10,678) Cash and cash equival
'/>"/>
SOURCE Pregis Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Pregis Announces Investor Conference Call to Review Fourth Quarter and Full Year 2008 Financial Results
2. Pregis Announces Third Quarter 2008 Financial Results
3. Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results
4. Pregis Announces Second Quarter 2008 Financial Results
5. Pregis Announces First Quarter 2008 Financial Results
6. Pregis Announces Fouth Quarter and Full Year 2007 Financial Results
7. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
8. Pregis Corporation Appoints New President of Protective Packaging North America
9. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
10. Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
11. Mylan Announces Intention to Purchase Remaining Interest in Matrix Laboratories and Delist Matrix from Indian Stock Exchanges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... October 01, 2014 Familylifeinsurancequotes.org has ... life insurance for senior citizens. , Senior citizens ... will now sell coverage to seniors who are over ... be purchased without taking a medical examination. , Term ... online and senior clients can qualify. Having life insurance ...
(Date:10/1/2014)... 01, 2014 Insuranceragents.info has released ... good life insurance plan for vulnerable family members. , ... family members. Providers in the family should always carry ... financial hardships for the rest of the family. ... Families can benefit more from temporary coverage or from ...
(Date:10/1/2014)... Lifeinsurance-policy.com has released a new blog post explaining how ... , Smoking will always have a negative impact on ... method to find affordable coverage. Insurance brokerage websites specialize ... , Whole life insurance premiums will be fixed throughout ... is permanent, the initial rates are very important. ...
(Date:10/1/2014)... Phoseon Technology, the pioneer in developing ... business worldwide. This rapid growth includes increased hiring for ... efforts. The company has experienced average annual growth rates ... this growth to continue in the future as new ... , “We are very pleased that UV ...
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
Breaking Medicine News(10 mins):Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Farmington Company Launches Rebrand and New Positioning 2
... to thwart tumor,s comeback , , WEDNESDAY, Jan. 21 ... cancer stem cells or "tumor-initiating cells" which, when targeted ... malignant. , The finding bolsters the theory that cancer ... are resistant to conventional therapies and responsible for tumor ...
... January 2009 - A new study conducted at the ... the University of Bologna, and published by Elsevier in ... http://www.elsevier.com/locate/cortex ) shows that, in confabulating patients, memory accuracy ... cognitive processes supporting adaptive behavior need attentional resources for ...
... Technical University of Catalonia (UPC) and Universitat Autnoma de ... (ESA) to design and carry out a scientific experiment ... between drugs and cells differ under these conditions. The ... Vaquer, with a doctorate in Medicine from UAB, and ...
... Erdman, A Cogdell,Spencer Company, a subsidiary of Cogdell ... broke ground earlier this week on two new medical ... , The two projects, a ... Jackson, Tennessee and a $1.75 million cancer center in,Mebane, ...
... 21 Amil,Participacoes S.A. (Bovespa: AMIL3) ("Amilpar"), informs its ... a meeting held today, approved the,payment of Interest on ... per,common share, corresponding to the total amount of R$ ... 2009, based on shareholders, position of,January 21, 2009. , ...
... & Friends Stage Show Kicks-off This Month Helping ... Raise Funds for Research. Autism Speaks, the ... yearlong partnership with Thomas & FriendsTM Live! On ... musical stage show produced by AEG ThemeSTAR and ...
Cached Medicine News:Health News:Targeting Cancer's Own Stem Cells to Fight Recurrence 2Health News:Targeting Cancer's Own Stem Cells to Fight Recurrence 3Health News:When less attention improves behavior 2Health News:Students from UAB and UPC will experiment under microgravity conditions at the ESA 2Health News:Students from UAB and UPC will experiment under microgravity conditions at the ESA 3Health News:Cogdell Spencer Breaks Ground on Projects in Tennessee and North Carolina 2Health News:Cogdell Spencer Breaks Ground on Projects in Tennessee and North Carolina 3Health News:Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock 2Health News:Autism Speaks Announces Yearlong Partnership With Thomas & Friends (TM) Live! On Stage: A Circus Comes To Town 2Health News:Autism Speaks Announces Yearlong Partnership With Thomas & Friends (TM) Live! On Stage: A Circus Comes To Town 3Health News:Autism Speaks Announces Yearlong Partnership With Thomas & Friends (TM) Live! On Stage: A Circus Comes To Town 4Health News:Autism Speaks Announces Yearlong Partnership With Thomas & Friends (TM) Live! On Stage: A Circus Comes To Town 5
(Date:9/30/2014)... Aileron Therapeutics, Inc. - Product Pipeline ... Direct,s, ,Aileron Therapeutics, Inc. - Product Pipeline Review ... Therapeutics, Inc.,s pharmaceutical research and development focus. ... therapeutic developmental pipeline of Aileron Therapeutics, Inc.,s, complete ... by drug target, mechanism of action (MoA), route ...
(Date:9/30/2014)... DALLAS , September 30, 2014 /PRNewswire/ ... market research report the "Glycobiology/Glycomics Market by Product ... Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, ... Forecast to 2019", published by MarketsandMarkets, provides ... restraints, challenges, opportunities, current market trends, and ...
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 ... stage. Growing ageing population and rise in the incidence ... of chronic wounds and in affordability of better quality ... Chinese wound care market. Universal coverage of public health ... products would further stimulate demand. Based on the findings ...
Breaking Medicine Technology:Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4China Wound Care Market 2China Wound Care Market 3
... Chamber Lenses: The Bausch & Lomb PMMA Posterior ... for primary implantation for the visual correction of ... older where a cataractous lens has been removed ... to be placed in the ciliary sulcus or ...
... are manufactured using the highest ... CQ UV PMMA material is ... single piece lenses. Unioptic lens ... nonphaco and phaco styles. All ...
... STAARVISC II is a sterile nonpyrogenic, ... hyaluronate. STAARVISC II contains 12 mg/ml of ... daltons) sodium hyaluronate dissolved in physiological saline. ... the viscosity is 105,000 cps (105 Pa ...
... viscoelastic agent for the surgeon who performs ... Amvisc possesses sufficient viscosity for excellent chamber ... cohesive so that complete removal at the ... quickly accomplished. Amvisc is priced to compete ...
Medicine Products: